Preferred Label : vadadustat;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.ema.europa.eu/en/medicines/human/EPAR/vafseo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
vadadustat
vadadustat
vadadustat
Hypoxia-Inducible Factor-Proline dioxygenases
enzyme inhibitors
enzyme inhibitors
anemia
renal insufficiency, chronic
Anemia of chronic renal failure (disorder)
renal dialysis
administration, oral
product surveillance, postmarketing
adult
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.